Every day, millions of Australians visit a pharmacy and pay a modest amount for medicines that would otherwise cost many times more. For many people, that affordability is not simply convenient—it is the difference between taking prescribed treatment and going without.

The Pharmaceutical Benefits Scheme (PBS) is one of Australia's most significant public health programs. While hospitals, ambulances and Medicare often receive public attention, the PBS quietly improves health outcomes every day by ensuring essential medicines remain affordable.

What is the PBS?

The Pharmaceutical Benefits Scheme is an Australian Government program that subsidises the cost of approved prescription medicines.

Instead of patients paying the full commercial price, the Commonwealth pays much of the cost directly to pharmacies and medicine suppliers.

Patients contribute only a regulated co-payment, with concession card holders paying substantially less.

Without the PBS, many modern medicines would simply be unaffordable for ordinary Australians.

Who pays for it?

The PBS is funded by Australian taxpayers through the Federal Government.

Each year, billions of dollars are allocated in the Commonwealth Budget to subsidise medicines.

The investment is substantial, but supporters argue it reduces much larger costs elsewhere in the health system by helping people stay healthier, avoid hospital admissions and better manage chronic illnesses.

Treating disease early is often considerably less expensive than treating complications later.

Who decides which medicines are included?

Medicines are not automatically added simply because they become available.

Before a medicine receives PBS funding it undergoes a rigorous assessment.

An independent expert body, the Pharmaceutical Benefits Advisory Committee (PBAC), examines evidence including:

• Clinical effectiveness
• Safety
• Comparison with existing treatments
• Cost-effectiveness
• Value for Australian taxpayers

Only after favourable recommendations and subsequent pricing negotiations with the manufacturer can a medicine be listed on the PBS.

This process aims to ensure Australians receive treatments that are both medically effective and represent responsible use of public funds.

Can medicines be removed?

Yes, although removal is relatively uncommon.

Medicines may be delisted if:

• newer and more effective treatments become available
• significant safety concerns emerge
• manufacturers cease supplying the medicine
• commercial arrangements change.

In many cases, older medicines remain available because they continue to benefit particular groups of patients.

The PBS is therefore continually reviewed rather than remaining fixed.

Why affordability matters

For people living with diabetes, heart disease, asthma, arthritis, cancer, mental illness and many other long-term conditions, treatment often continues for years or even decades.

If medicines become too expensive, some patients delay filling prescriptions, reduce doses or stop treatment altogether.

Medical researchers have consistently found that affordability is an important factor in whether patients continue taking prescribed medicines.

Lower medicine costs can therefore improve adherence, leading to better health outcomes and reducing preventable complications.

More than saving money

The PBS is about far more than reducing pharmacy bills.

Affordable medicines can help people continue working, care for their families, remain independent for longer and enjoy a better quality of life.

Parents are better able to care for children.

Older Australians can remain active within their communities.

People with chronic illnesses often experience fewer interruptions to daily life because effective treatment remains within financial reach.

For many Australians, continuity of treatment provides not only better health but also confidence that a diagnosis does not necessarily mean financial hardship.

Looking ahead

Medical science continues to produce increasingly sophisticated—and increasingly expensive—treatments.

The challenge for governments will be balancing innovation with affordability, ensuring Australians continue to receive access to modern medicines while maintaining a financially sustainable health system.

The PBS has evolved for decades and will almost certainly continue to evolve as new therapies emerge.

The Times View

The Pharmaceutical Benefits Scheme is one of Australia's quiet success stories. Most Australians interact with it only when collecting a prescription, yet its impact reaches into almost every family. By making essential medicines affordable, it helps people live longer, manage chronic illness more effectively and avoid unnecessary hospital care. Like all publicly funded programs, it must continually balance medical innovation with responsible spending, but its underlying purpose remains simple: ensuring that access to essential medicines depends primarily on medical need rather than personal wealth.